GB201416622D0 - Pharmaceutical compounds - Google Patents

Pharmaceutical compounds

Info

Publication number
GB201416622D0
GB201416622D0 GBGB1416622.7A GB201416622A GB201416622D0 GB 201416622 D0 GB201416622 D0 GB 201416622D0 GB 201416622 A GB201416622 A GB 201416622A GB 201416622 D0 GB201416622 D0 GB 201416622D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compounds
pharmaceutical
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1416622.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Heptares Therapeutics Ltd
Original Assignee
Heptares Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Heptares Therapeutics Ltd filed Critical Heptares Therapeutics Ltd
Priority to GBGB1416622.7A priority Critical patent/GB201416622D0/en
Publication of GB201416622D0 publication Critical patent/GB201416622D0/en
Priority to NZ723103A priority patent/NZ723103A/en
Priority to LTEP15703826.6T priority patent/LT3102568T/en
Priority to CA2938169A priority patent/CA2938169C/en
Priority to ES15703826.6T priority patent/ES2688548T3/en
Priority to CN201910003375.6A priority patent/CN109851610B/en
Priority to MX2020001236A priority patent/MX2020001236A/en
Priority to SG11201606269WA priority patent/SG11201606269WA/en
Priority to CN201580017993.6A priority patent/CN106458986B/en
Priority to BR112016017979-0A priority patent/BR112016017979B1/en
Priority to AU2015213900A priority patent/AU2015213900B2/en
Priority to RU2016133684A priority patent/RU2685230C2/en
Priority to SI201530399T priority patent/SI3102568T1/en
Priority to JP2016550483A priority patent/JP6479029B2/en
Priority to PT15703826T priority patent/PT3102568T/en
Priority to DK15703826.6T priority patent/DK3102568T3/en
Priority to PL15703826T priority patent/PL3102568T3/en
Priority to EP15703826.6A priority patent/EP3102568B1/en
Priority to RS20181127A priority patent/RS57843B1/en
Priority to US15/117,018 priority patent/US9670183B2/en
Priority to PCT/GB2015/050331 priority patent/WO2015118342A1/en
Priority to EP18179258.1A priority patent/EP3406609A1/en
Priority to UAA201609185A priority patent/UA122121C2/en
Priority to MX2016010322A priority patent/MX371529B/en
Priority to KR1020167024572A priority patent/KR102352388B1/en
Priority to IL247117A priority patent/IL247117B/en
Priority to SA516371614A priority patent/SA516371614B1/en
Priority to CL2016001983A priority patent/CL2016001983A1/en
Priority to PH12016501570A priority patent/PH12016501570B1/en
Priority to US15/591,605 priority patent/US9926297B2/en
Priority to HK17105049.1A priority patent/HK1231473A1/en
Priority to US15/902,537 priority patent/US10196380B2/en
Priority to HRP20181499TT priority patent/HRP20181499T1/en
Priority to CY181100996T priority patent/CY1120834T1/en
Priority to US16/217,570 priority patent/US10385039B2/en
Priority to JP2019017086A priority patent/JP6774513B2/en
Priority to AU2019201579A priority patent/AU2019201579B2/en
Priority to US16/459,179 priority patent/US10689368B2/en
Priority to US16/904,099 priority patent/US10961225B2/en
Priority to JP2020168341A priority patent/JP2021006571A/en
Priority to AU2020277225A priority patent/AU2020277225A1/en
Priority to JP2023060030A priority patent/JP2023073504A/en
Priority to JP2023076024A priority patent/JP2023087045A/en
Priority to JP2023076025A priority patent/JP2023087046A/en
Ceased legal-status Critical Current

Links

GBGB1416622.7A 2014-02-06 2014-09-19 Pharmaceutical compounds Ceased GB201416622D0 (en)

Priority Applications (44)

Application Number Priority Date Filing Date Title
GBGB1416622.7A GB201416622D0 (en) 2014-09-19 2014-09-19 Pharmaceutical compounds
KR1020167024572A KR102352388B1 (en) 2014-02-06 2015-02-06 Bicyclic aza compounds as muscarinic m1 receptor and/or m4 receptor agonists
PCT/GB2015/050331 WO2015118342A1 (en) 2014-02-06 2015-02-06 Bicyclic aza compounds as muscarinic m1 receptor agonists.
UAA201609185A UA122121C2 (en) 2014-02-06 2015-02-06 Bicyclic aza compounds as muscarinic m1 receptor and/or m4 receptor agonists
CA2938169A CA2938169C (en) 2014-02-06 2015-02-06 Bicyclic aza compounds as muscarinic m1 receptor agonists
LTEP15703826.6T LT3102568T (en) 2014-02-06 2015-02-06 Bicyclic aza compounds as muscarinic m1 receptor agonists.
CN201910003375.6A CN109851610B (en) 2014-02-06 2015-02-06 Bicyclic aza compounds as muscarinic M1 and/or M4 receptor agonists
MX2020001236A MX2020001236A (en) 2014-02-06 2015-02-06 Bicyclic aza compounds as muscarinic m1 receptor and/or m4 receptor agonists.
SG11201606269WA SG11201606269WA (en) 2014-02-06 2015-02-06 Bicyclic aza compounds as muscarinic m1 receptor and/or m4 receptor agonists
CN201580017993.6A CN106458986B (en) 2014-02-06 2015-02-06 Azabicyclo compound as muscarine M1 and/or M4 receptor stimulating agent
BR112016017979-0A BR112016017979B1 (en) 2014-02-06 2015-02-06 BICYCLIC AZA COMPOUNDS AS MUSCARINE M1 RECEPTOR AGONISTS, PHARMACEUTICAL COMPOSITION COMPRISING SUCH COMPOUNDS AND THERAPEUTIC USE THEREOF
AU2015213900A AU2015213900B2 (en) 2014-02-06 2015-02-06 Bicyclic aza compounds as muscarinic M1 receptor and/or M4 receptor agonists
EP18179258.1A EP3406609A1 (en) 2014-02-06 2015-02-06 Bicyclic aza compounds as muscarinic receptor agonists
SI201530399T SI3102568T1 (en) 2014-02-06 2015-02-06 Bicyclic aza compounds as muscarinic m1 receptor agonists.
MX2016010322A MX371529B (en) 2014-02-06 2015-02-06 Bicyclic aza compounds as muscarinic m1 receptor and/or m4 receptor agonists.
PT15703826T PT3102568T (en) 2014-02-06 2015-02-06 Bicyclic aza compounds as muscarinic m1 receptor agonists.
DK15703826.6T DK3102568T3 (en) 2014-02-06 2015-02-06 BICYCLIC AZA RELATIONS AS MUSCARIN-M1 RECEPTOR AGONISTS
PL15703826T PL3102568T3 (en) 2014-02-06 2015-02-06 Bicyclic aza compounds as muscarinic m1 receptor agonists.
EP15703826.6A EP3102568B1 (en) 2014-02-06 2015-02-06 Bicyclic aza compounds as muscarinic m1 receptor agonists.
RS20181127A RS57843B1 (en) 2014-02-06 2015-02-06 Bicyclic aza compounds as muscarinic m1 receptor agonists
US15/117,018 US9670183B2 (en) 2014-02-06 2015-02-06 Bicyclic AZA compounds as muscarinic M1 receptor and/or M4 receptor agonists
NZ723103A NZ723103A (en) 2014-02-06 2015-02-06 Bicyclic aza compounds as muscarinic m1 receptor and/or m4 receptor agonists
RU2016133684A RU2685230C2 (en) 2014-02-06 2015-02-06 Bicyclic nitrogen-containing compounds as muscarinic m1 receptor agonists
ES15703826.6T ES2688548T3 (en) 2014-02-06 2015-02-06 Bicyclic aza compounds as M1 muscarinic receptor agonists
JP2016550483A JP6479029B2 (en) 2014-02-06 2015-02-06 Bicyclic aza compounds as muscarinic M1 receptor agonists
IL247117A IL247117B (en) 2014-02-06 2016-08-04 2-substituted derivatives of alkyl azaspiro[3,4]octane-6-carboxylates as muscarinic m1 receptor and/or m4 receptor agonists
SA516371614A SA516371614B1 (en) 2014-02-06 2016-08-04 Bicyclic Aza Compounds as Muscarinic M1 Receptor and/or M4 Receptor Agonists
CL2016001983A CL2016001983A1 (en) 2014-02-06 2016-08-05 Bicyclic aza compounds as muscarinic receptor agonists m1 and / or m4
PH12016501570A PH12016501570B1 (en) 2014-02-06 2016-08-08 Bicyclic aza compounds as muscarinic m1 receptor and/or m4 receptor agonists
US15/591,605 US9926297B2 (en) 2014-02-06 2017-05-10 Bicyclic AZA compounds as muscarinic M1 receptor and/or M4 receptor agonists
HK17105049.1A HK1231473A1 (en) 2014-02-06 2017-05-19 Bicyclic aza compounds as muscarinic m1 receptor and/or m4 receptor agonists m1 / m4
US15/902,537 US10196380B2 (en) 2014-02-06 2018-02-22 Bicyclic aza compounds as muscarinic M1 receptor and/or M4 receptor agonists
HRP20181499TT HRP20181499T1 (en) 2014-02-06 2018-09-20 Bicyclic aza compounds as muscarinic m1 receptor agonists
CY181100996T CY1120834T1 (en) 2014-02-06 2018-09-27 BICYCLE NITROGEN COMPOUNDS AS MUSCARINE RECONCISTS M1
US16/217,570 US10385039B2 (en) 2014-02-06 2018-12-12 Bicyclic aza compounds as muscarnic M1 receptor and/or M4 receptor antagonists
JP2019017086A JP6774513B2 (en) 2014-02-06 2019-02-01 Bicyclic aza compound as a muscarinic M1 receptor agonist
AU2019201579A AU2019201579B2 (en) 2014-02-06 2019-03-07 Bicyclic aza compounds as muscarinic M1 receptor and/or M4 receptor agonists
US16/459,179 US10689368B2 (en) 2014-02-06 2019-07-01 Bicyclic aza compounds as muscarinic M1 receptor and/or M4 receptor
US16/904,099 US10961225B2 (en) 2014-02-06 2020-06-17 Bicyclic AZA compounds as muscarinic M1 receptor and/or M4 receptor
JP2020168341A JP2021006571A (en) 2014-02-06 2020-10-05 Bicyclic aza compound as muscarinic m1 receptor agonist
AU2020277225A AU2020277225A1 (en) 2014-02-06 2020-11-26 Bicyclic aza compounds as muscarinic M1 receptor and/or M4 receptor agonists
JP2023060030A JP2023073504A (en) 2014-02-06 2023-04-03 Bicyclic Aza Compounds as Muscarinic M1 Receptor Agonists
JP2023076024A JP2023087045A (en) 2014-02-06 2023-05-02 Bicyclic Aza Compounds as Muscarinic M1 Receptor Agonists
JP2023076025A JP2023087046A (en) 2014-02-06 2023-05-02 Bicyclic Aza Compounds as Muscarinic M1 Receptor Agonists

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1416622.7A GB201416622D0 (en) 2014-09-19 2014-09-19 Pharmaceutical compounds

Publications (1)

Publication Number Publication Date
GB201416622D0 true GB201416622D0 (en) 2014-11-05

Family

ID=51869203

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1416622.7A Ceased GB201416622D0 (en) 2014-02-06 2014-09-19 Pharmaceutical compounds

Country Status (1)

Country Link
GB (1) GB201416622D0 (en)

Similar Documents

Publication Publication Date Title
IL270954A (en) Pharmaceutical compounds
IL258213A (en) Pharmaceutical compounds
GB201419579D0 (en) Pharmaceutical compound
GB201414730D0 (en) Pharmaceutical compound
GB201506658D0 (en) Pharmaceutical compounds
IL258246A (en) Pharmaceutical compounds
GB201404922D0 (en) Pharmaceutical compounds
GB201504675D0 (en) Pharmaceutical compounds
GB201506660D0 (en) Pharmaceutical compounds
GB201409471D0 (en) Pharmaceutical composition
GB201519352D0 (en) Pharmaceutical compounds
GB201409485D0 (en) Pharmaceutical composition
GB201409488D0 (en) Pharmaceutical composition
GB201506933D0 (en) Pharmaceutical compounds
GB201502567D0 (en) Pharmaceutical compounds
GB201416513D0 (en) Pharmaceutical compounds
GB201417707D0 (en) Pharmaceutical compounds
PT3089740T (en) Pharmaceutical composition
GB2529605B (en) Pharmaceutical composition
GB201508022D0 (en) Pharmaceutical compounds
GB201517451D0 (en) Pharmaceutical compounds
GB201416968D0 (en) Pharmaceutical compounds
GB201416969D0 (en) Pharmaceutical compounds
GB201416625D0 (en) Pharmaceutical compounds
GB201416622D0 (en) Pharmaceutical compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)